This study aims to address the following questions: (1) What are the expression levels of lncRNAs MEG3, PINT and GAS5 in the context of diagnosis, clinical metrics and symptomatology in a sample of participants with psychosis (schizophrenia, bipolar disorder) and non-clinical controls? This evidence concerns the gene GAS5 and psychotic disorder.